loadpatents
Patent applications and USPTO patent grants for Kinch; Michael S..The latest application filed is for "epha2 t-cell epitope agonists and uses therefore".
Patent | Date |
---|---|
Epha2 T-cell Epitope Agonists And Uses Therefore App 20210198333 - Storkus; Walter J. ;   et al. | 2021-07-01 |
EPHA2 t-cell epitope agonists and uses therefore Grant 10,781,240 - Storkus , et al. Sept | 2020-09-22 |
Epha2 T-cell Epitope Agonists And Uses Therefore App 20190023756 - Storkus; Walter J. ;   et al. | 2019-01-24 |
EphA2 T-cell epitope agonists and uses therefore Grant 10,131,699 - Storkus , et al. November 20, 2 | 2018-11-20 |
Epha2 T-cell Epitope Agonists And Uses Therefore App 20170002050 - STORKUS; WALTER J. ;   et al. | 2017-01-05 |
EphA2 T-cell epitope agonists and uses therefore Grant 9,359,402 - Storkus , et al. June 7, 2 | 2016-06-07 |
Random Homozygous Gene Perturbation (rhgp) With Thermal Assymetric Interlaced (tail)-pcr App 20140271671 - Kinch; Michael S. ;   et al. | 2014-09-18 |
Epha2 T-cell Epitope Agonists And Uses Therefore App 20140134198 - Storkus; Walter J. ;   et al. | 2014-05-15 |
EPHA2 as a therapeutic target for cancer Grant 8,591,887 - Kinch , et al. November 26, 2 | 2013-11-26 |
Methods of inhibiting HIV infectivity Grant 8,535,684 - Kinch , et al. September 17, 2 | 2013-09-17 |
EphA2 T-Cell Epitopes and Uses Therefor App 20120201840 - Storkus; Walter J. ;   et al. | 2012-08-09 |
Antibodies As A Cancer Diagnostic App 20120122112 - KINCH; Michael S. ;   et al. | 2012-05-17 |
Modulators Of EphA2 And Ephrina1 For The Treatment Of Fibrosis-Related Disease App 20120121582 - Kinch; Michael S. ;   et al. | 2012-05-17 |
EphA2 T-cell epitopes and uses therefor Grant 8,114,407 - Storkus , et al. February 14, 2 | 2012-02-14 |
Toxin Conjugated Eph Receptor Antibodies App 20110280892 - Kinch; Michael S. ;   et al. | 2011-11-17 |
EPHA2 as a therapeutic target for cancer App 20110150898 - Kinch; Michael S. ;   et al. | 2011-06-23 |
Diagnosis Of Pre-cancerous Conditions Using Pcdgf Agents App 20110053182 - KINCH; MICHAEL S. ;   et al. | 2011-03-03 |
EphA2 AGONISTIC MONOCLONAL ANTIBODIES AND METHODS OF USE THEREOF App 20100298545 - Kinch; Michael S. ;   et al. | 2010-11-25 |
Epha2 Monoclonal Antibodies And Methods Of Use Thereof App 20100278838 - Kinch; Michael S. ;   et al. | 2010-11-04 |
Modulators of EphA2 and Ephrin-A1 for the treatment of fibrosis-related disease App 20100260749 - Kinch; Michael S. ;   et al. | 2010-10-14 |
EphA2 as a therapeutic target for cancer Grant 7,776,327 - Kinch , et al. August 17, 2 | 2010-08-17 |
Random Homozygous Gene Perturbation (rhgp) With Thermal Assymetric Interlaced (tail)-pcr App 20100183628 - Kinch; Michael S. ;   et al. | 2010-07-22 |
USE OF EphA4 AND MODULATOR OF EphA4 FOR DIAGNOSIS, TREATMENT AND PREVENTION OF CANCER App 20100166657 - Kinch; Michael S. ;   et al. | 2010-07-01 |
Epha2 Agonistic Monoclonal Antibodies And Methods Of Use Thereof App 20100143345 - Kinch; Michael S. ;   et al. | 2010-06-10 |
Low molecular weight protein tyrosine phosphatase (LMW-PTP) as a diagnostic and therapeutic target Grant 7,662,770 - Kinch February 16, 2 | 2010-02-16 |
Compounds, Pharmaceutical Compositions An Dmethods For Inhibiting Hiv Infectivity App 20100035925 - Goldblatt; Michael ;   et al. | 2010-02-11 |
Toxin Conjugated Eph Receptor Antibodies App 20090304721 - Kinch; Michael S. ;   et al. | 2009-12-10 |
EphA4 Antibodies Grant 7,604,799 - Kinch , et al. October 20, 2 | 2009-10-20 |
Epha2 And Hyperproliferative Cell Disorders App 20090162933 - Kiener; Peter A. ;   et al. | 2009-06-25 |
EphA2 T-cell epitopes and uses therefor App 20080226665 - Storkus; Walter J. ;   et al. | 2008-09-18 |
EphA2, EphA4 and LMW-PTP and methods of treatment of hyperproliferative cell disorders App 20080089931 - Kinch; Michael S. | 2008-04-17 |
EphA2 BiTE molecules and uses thereof App 20080044413 - Hammond; Scott A. ;   et al. | 2008-02-21 |
Non-human Primate Receptor Tyrosine Kinases App 20080003210 - Bruckheimer; Elizabeeth ;   et al. | 2008-01-03 |
EphA2 T-cell epitopes and uses therefor Grant 7,297,337 - Storkus , et al. November 20, 2 | 2007-11-20 |
EpA2 monoclonal antibodies and methods of use thereof App 20070166314 - Kinch; Michael S. ;   et al. | 2007-07-19 |
Antibodies as a cancer diagnostic App 20070161064 - Kinch; Michael S. ;   et al. | 2007-07-12 |
EphA2 agonistic monoclonal antibodies and methods of use thereof App 20070134254 - Kinch; Michael S. ;   et al. | 2007-06-14 |
EphA2 agonistic monoclonal antibodies and methods of use thereof App 20070086943 - Kinch; Michael S. ;   et al. | 2007-04-19 |
Diagnosis of pre-cancerous conditions using pcdgf agents App 20070065887 - Kinch; Michael S. | 2007-03-22 |
EphA2 as a diagnostic target for metastatic cancer Grant 7,192,698 - Kinch , et al. March 20, 2 | 2007-03-20 |
Modulation of antibody specificity by tailoring the affinity to cognate antigens App 20060121042 - Dall'Acqua; William ;   et al. | 2006-06-08 |
Use of modulators of EphA2 and EphrinA1 for the treatment and prevention of infections App 20060121043 - Kinch; Michael S. ;   et al. | 2006-06-08 |
Modulators of EphA2 and EphrinA1 for the treatment of fibrosis-related disease App 20060122138 - Kinch; Michael S. ;   et al. | 2006-06-08 |
Low molecular weight protein tyrosine phosphatase (lmw-ptp) as a diagnostic and therapeutic target App 20060093608 - Kinch; Michael S. | 2006-05-04 |
EphA2 as a therapeutic target for cancer App 20060088541 - Kinch; Michael S. ;   et al. | 2006-04-27 |
EphA2 T-cell epitopes and uses therefor App 20060019899 - Storkus; Walter J. ;   et al. | 2006-01-26 |
Listeria-based EphA2 vaccines App 20050281783 - Kinch, Michael S. ;   et al. | 2005-12-22 |
Treatment of metastatic disease Grant 6,927,203 - Kinch , et al. August 9, 2 | 2005-08-09 |
EphA2 as a therapeutic target for cancer App 20050169931 - Kinch, Michael S. ;   et al. | 2005-08-04 |
EphA2 agonistic monoclonal antibodies and methods of use thereof App 20050152899 - Kinch, Michael S. ;   et al. | 2005-07-14 |
Targeted drug delivery using EphA2 or EphA4 binding moieties App 20050153923 - Kinch, Michael S. | 2005-07-14 |
EphA2, EphA4 and LMW-PTP and methods of treatment of hyperproliferative cell disorders App 20050147593 - Kinch, Michael S. | 2005-07-07 |
EphA2 and hyperproliferative cell disorders App 20050059592 - Kiener, Peter A. ;   et al. | 2005-03-17 |
EphA2 T-cell epitope agonists and uses therefor App 20050048550 - Storkus, Walter J. ;   et al. | 2005-03-03 |
EphA2, hypoproliferative cell disorders and epithelial and endothelial reconstitution App 20050049176 - Kiener, Peter A. ;   et al. | 2005-03-03 |
Use of EphA4 and modulator of EphA4 for diagnosis, treatment and prevention of cancer App 20050013819 - Kinch, Michael S. ;   et al. | 2005-01-20 |
EphA2 agonistic monoclonal antibodies and methods of use thereof App 20040091486 - Kinch, Michael S. ;   et al. | 2004-05-13 |
EphA2 monoclonal antibodies and methods of use thereof App 20040028685 - Kinch, Michael S. ;   et al. | 2004-02-12 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.